Oncology PracticeFDA OKs first oral hormone therapy for advanced prostate cancerDecember 18, 2020Genitourinary Cancer
Oncology PracticeMargetuximab approved for HER2-positive metastatic breast cancerDecember 18, 2020Breast CancerMetastatic Breast Cancer
Hematology NewsVaccine rollout on track, expect 300 million doses through March: FedsDecember 17, 2020COVID-19 Updates
Hematology NewsFDA safety alert: Face masks with metal can burn during MRIDecember 9, 2020COVID-19 Updates
Oncology PracticeFDA approves first agent for PSMA-PET imaging in prostate cancerDecember 2, 2020Genitourinary CancerProstate Cancer
Oncology PracticeNew drug approved for relapsed/refractory neuroblastomaNovember 30, 2020Neuro-oncologyPediatrics
Hematology NewsCDC panel delves into priorities for COVID vaccine distributionNovember 25, 2020COVID-19 Updates
Oncology PracticePembrolizumab approved for triple-negative breast cancerNovember 16, 2020Breast CancerMetastatic Breast Cancer
Hematology NewsNearly 10% of hospitalized patients with COVID-19 later readmittedNovember 12, 2020COVID-19 Updates
Hematology NewsCDC panel takes on COVID vaccine rollout, risks, and side effectsNovember 2, 2020COVID-19 Updates
Hematology NewsFDA posts COVID vaccine guidance amid White House pushbackOctober 7, 2020COVID-19 Updates
Oncology PracticeFDA OKs combination immunotherapy for first-line mesothelioma treatmentOctober 5, 2020Lung Cancer
